Results 71 to 80 of about 238 (95)
On the low reproducibility of cancer studies. [PDF]
Wen H, Wang HY, He X, Wu CI.
europepmc +1 more source
Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors. [PDF]
Wong SJ +16 more
europepmc +1 more source
Mechanistic Insights into Alternative Gene Splicing in Oxidative Stress and Tissue Injury. [PDF]
Dery KJ +3 more
europepmc +1 more source
Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells. [PDF]
Kim DS +4 more
europepmc +1 more source
Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response. [PDF]
Warfvinge R +10 more
europepmc +1 more source
Giant aortic aneurysm due to fibulin- 4 deficiency: case series. [PDF]
Sülü A, Başpınar O, Şahin DA.
europepmc +1 more source
Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy. [PDF]
Chomel JC, Turhan AG.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Leukemia & Lymphoma, 1998
Following the discovery of the p210bcrabl protein product of the bcrabl chimeric fusion gene generated by the Philadelphia chromosome translocation in chronic myelogenous leukemia (CML), structure function studies quickly identified which parts of this molecule were playing a role in the generation of the phenotypes of growth factor independent growth,
X Y, Guo +3 more
openaire +4 more sources
Following the discovery of the p210bcrabl protein product of the bcrabl chimeric fusion gene generated by the Philadelphia chromosome translocation in chronic myelogenous leukemia (CML), structure function studies quickly identified which parts of this molecule were playing a role in the generation of the phenotypes of growth factor independent growth,
X Y, Guo +3 more
openaire +4 more sources
Oncogene, 1993
The t(9,22) chromosomal translocation generating the Philadelphia chromosome and the BCRABL oncogene has been shown both cytogenetically and molecularly to be the etiologic event in chronic myelogenous leukemia (CML). We have designed a ribozyme to cleave the BCRABL mRNA by targeting a GUU triplet adjacent to the junction of the c-BCR and c-ABL fused ...
S K, Shore, P M, Nabissa, E P, Reddy
openaire +1 more source
The t(9,22) chromosomal translocation generating the Philadelphia chromosome and the BCRABL oncogene has been shown both cytogenetically and molecularly to be the etiologic event in chronic myelogenous leukemia (CML). We have designed a ribozyme to cleave the BCRABL mRNA by targeting a GUU triplet adjacent to the junction of the c-BCR and c-ABL fused ...
S K, Shore, P M, Nabissa, E P, Reddy
openaire +1 more source

